Re:AI in drug discovery is overhyped: examples from AstraZen...
by mmmrtl on Friday January 05, 2018 @02:40PM
(#16081034)
A bit removed from drug targets, but have you seen AMELIE - it's for ranking causal variants (genetic mutations) for patients based on literature + patient's phenotype?
https://www.biorxiv.org/content/early/2017/08/02/171322
I'm not in the NLP field, but this does seem like a legitimate use